Onyx Biotec

70.65
+1.70
(2.47%)
Market Cap
128.10
Eps
2.54
PE Ratio (TTM)
41.29
Dividend Yield
0.00
Industry
0.00
52 Week High
97.45
52 Week low
51.00
PB Ratio
2.31
Debt to Equity
1.39
Sector
0.00
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
36.11 %
Net Income Growth
66.67 %
Cash Flow Change
-22.45 %
ROE
20.34 %
ROCE
48.45 %
EBITDA Margin (Avg.)
34.69 %

Yearly Financial Results

Annual Financials
2022
2023
2024
TTM
Revenue
45
40
54
0
Expenses
39
35
46
0
EBITDA
6
5
8
0
Operating Profit %
13 %
11 %
15 %
0 %
Depreciation
1
2
2
0
Interest
1
1
2
0
Profit Before Tax
4
3
4
0
Tax
0
1
1
0
Net Profit
3
2
3
0
EPS in ₹
2.84
1.56
2.54
0.00

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
37
59
74
Fixed Assets
17
43
44
Current Assets
14
15
30
Capital Work in Progress
4
0
0
Investments
0
0
0
Other Assets
16
16
31
Total Liabilities
37
59
74
Current Liabilities
10
20
23
Non Current Liabilities
10
20
27
Total Equity
16
18
25
Reserve & Surplus
11
12
12
Share Capital
6
6
13

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
-0
-4
2
Investing Activities
-6
-23
-3
Operating Activities
1
2
2
Financing Activities
5
16
3

Share Holding

% Holding
Nov 2024
Promoter
65.10 %
FIIs
0.00 %
DIIs
0.03 %
Government
0.00 %
Public / Retail
18.96 %
No of Share Holders
1,181

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
No data

Corporate Action

Technical Indicators

RSI(14)
Neutral
43.54
ATR(14)
Less Volatile
4.44
STOCH(9,6)
Neutral
28.73
STOCH RSI(14)
Oversold
18.55
MACD(12,26)
Bearish
-1.61
ADX(14)
Weak Trend
19.90
UO(9)
Bearish
55.12
ROC(12)
Downtrend But Slowing Down
-14.67
WillR(14)
Neutral
-76.46